Company Filing History:
Years Active: 1988
Title: Rolf W. Hartmann: Innovator in Antitumor Compounds
Introduction
Rolf W. Hartmann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Rolf W. Hartmann holds a patent for derivatives of antitumor compounds. This patent corresponds to a specific formula where the substituents R₁ and R₂ may vary, representing various chemical groups. The compounds are designed for use in treating estrogen-receptor-positive tumors and prostate carcinoma. He has 1 patent to his name, showcasing his expertise in this critical area of research.
Career Highlights
Throughout his career, Hartmann has been associated with Asta-Werke Aktiengesellschaft, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in cancer treatment, reflecting his commitment to improving patient outcomes.
Collaborations
Rolf W. Hartmann has collaborated with notable colleagues, including Helmut Schonenberger and Martin Schneider. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Rolf W. Hartmann's contributions to the field of antitumor compounds highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment, demonstrating the importance of innovation in healthcare.